Free Trial

Castle Biosciences (CSTL) Competitors

Castle Biosciences logo
$24.01 +0.55 (+2.34%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$24.01 0.00 (0.00%)
As of 08/29/2025 05:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CSTL vs. HTFL, CELC, ADUS, LFST, PGNY, ARDT, PACS, NHC, VRDN, and AVAH

Should you be buying Castle Biosciences stock or one of its competitors? The main competitors of Castle Biosciences include Heartflow (HTFL), Celcuity (CELC), Addus HomeCare (ADUS), LifeStance Health Group (LFST), Progyny (PGNY), Ardent Health (ARDT), PACS Group (PACS), National HealthCare (NHC), Viridian Therapeutics (VRDN), and Aveanna Healthcare (AVAH). These companies are all part of the "healthcare" industry.

Castle Biosciences vs. Its Competitors

Heartflow (NASDAQ:HTFL) and Castle Biosciences (NASDAQ:CSTL) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, media sentiment, valuation, dividends, earnings, institutional ownership and analyst recommendations.

Castle Biosciences has higher revenue and earnings than Heartflow.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HeartflowN/AN/AN/AN/AN/A
Castle Biosciences$332.07M2.10$18.25M-$0.35-68.60

Castle Biosciences has a consensus target price of $37.00, indicating a potential upside of 54.10%. Given Castle Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Castle Biosciences is more favorable than Heartflow.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Heartflow
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Castle Biosciences
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.89

Heartflow has a net margin of 0.00% compared to Castle Biosciences' net margin of -2.73%. Castle Biosciences' return on equity of 2.37% beat Heartflow's return on equity.

Company Net Margins Return on Equity Return on Assets
HeartflowN/A N/A N/A
Castle Biosciences -2.73%2.37%2.03%

In the previous week, Castle Biosciences had 5 more articles in the media than Heartflow. MarketBeat recorded 7 mentions for Castle Biosciences and 2 mentions for Heartflow. Castle Biosciences' average media sentiment score of 1.35 beat Heartflow's score of 0.93 indicating that Castle Biosciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Heartflow
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Castle Biosciences
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

92.6% of Castle Biosciences shares are owned by institutional investors. 7.2% of Castle Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Castle Biosciences beats Heartflow on 10 of the 11 factors compared between the two stocks.

Get Castle Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for CSTL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CSTL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CSTL vs. The Competition

MetricCastle BiosciencesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$696.49M$3.08B$5.69B$9.74B
Dividend YieldN/A2.28%6.64%4.48%
P/E Ratio68.6020.9283.1926.59
Price / Sales2.10352.35515.16159.07
Price / Cash24.4043.5325.6628.92
Price / Book1.479.7811.766.08
Net Income$18.25M-$54.01M$3.27B$265.93M
7 Day Performance16.72%0.10%1.13%0.36%
1 Month Performance63.89%8.52%8.30%5.58%
1 Year Performance-19.08%7.03%62.26%19.67%

Castle Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CSTL
Castle Biosciences
2.5323 of 5 stars
$24.01
+2.3%
$37.00
+54.1%
-19.1%$696.49M$332.07M68.60540News Coverage
Positive News
HTFL
Heartflow
N/A$29.84
+2.3%
N/AN/A$2.37BN/A0.00699
CELC
Celcuity
1.7422 of 5 stars
$49.25
-6.0%
$50.60
+2.7%
+221.0%$2.22BN/A-14.2840
ADUS
Addus HomeCare
4.8951 of 5 stars
$116.65
-1.5%
$138.38
+18.6%
-13.4%$2.18B$1.15B25.7549,703Positive News
LFST
LifeStance Health Group
3.3533 of 5 stars
$5.39
-2.9%
$8.50
+57.7%
-13.2%$2.16B$1.25B-107.8010,218
PGNY
Progyny
2.9606 of 5 stars
$23.14
-1.7%
$25.10
+8.5%
+0.8%$2.02B$1.17B39.22310News Coverage
Positive News
ARDT
Ardent Health
3.4258 of 5 stars
$12.70
-2.2%
$19.56
+54.1%
-36.0%$1.86B$5.97B7.0124,900Positive News
PACS
PACS Group
2.8649 of 5 stars
$11.75
-2.5%
$33.33
+183.7%
-70.7%$1.84B$3.56B0.0032,433
NHC
National HealthCare
N/A$111.98
-2.5%
N/A-17.2%$1.74B$1.46B14.0312,400Positive News
VRDN
Viridian Therapeutics
1.8746 of 5 stars
$18.57
-3.4%
$37.78
+103.4%
+25.2%$1.57B$300K-4.8550News Coverage
Positive News
AVAH
Aveanna Healthcare
2.3898 of 5 stars
$7.43
-0.5%
$7.50
+0.9%
+41.6%$1.56B$2.02B92.8833,500Positive News

Related Companies and Tools


This page (NASDAQ:CSTL) was last updated on 9/1/2025 by MarketBeat.com Staff
From Our Partners